We therefore explored whether new prognostic groups within the larger MSI-negative subset could be identified with KRAS, BRAF, and TP53, given that TP53 mutation remained an independent prognostic marker when MSI-positive and ultramutator colorectal cancers were excluded from the main analysis based on gene panels (table 1). Here, KRAS is linked to colorectal cancer.